Hackensack Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Hackensack
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Hackensack News
Hackensack to hold Cinco de Mayo pub crawl. Here's what to expect
After Main Street’s St. Patrick’s Day pub crawl drew more than 350 people, another is planned in the city’s downtown to celebrate Cinco de Mayo.
Will NY curb NY Power Authority's use of .5M plane? What we know now
NY Senate Majority Leader Andrea Stewart-Cousins is pressing the Hochul administration for answers about why NYPA continues flying a .5M plane.
CBRE Provides M Agency Loan for Refinancing of Prospect Place Apartments in Hackensack
CBRE has provided a million Freddie Mac loan for the refinancing of Prospect Place, a 360-unit apartment complex in Hackensack. Prospect Place consists of two buildings: an 18-story tower with 157 ...
BioVersys Strengthens Ansamycin Platform and NTM Research Through Collaboration and License Agreement with Hackensack Meridian Health
BioVersys strengthens its Ansamycin Chemistry platform and research on tackling difficult-to-treat non-tuberculous mycobacteria (NTM) diseases. BioVersys joins forces with Hackensack Meridian Health ...